| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |